Da32 Life Science Tech Acquisition Stock Price, News & Analysis
Company Description
Da32 Life Science Tech Acquisition (NASDAQ: DALS) is a publicly traded company. The company has a market capitalization of $264.2M.
DALS stock has declined 100.0% over the past year.
This page provides a comprehensive overview of DALS stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Da32 Life Science Tech Acquisition (DALS) stock. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $264.2M, DALS is classified as a micro-cap stock with approximately 25.6M shares outstanding.
Latest News
Da32 Life Science Tech Acquisition has 3 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. Key topics include acquisition, IPO, offering. View all DALS news →